\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ palpable\\ abnormalities\\ in\\ the\\ breast\\.\\ \\ two\\ small\\ skin\\ moles\\,\\ marked\\ with\\ metallic\\ bb\\'s\\.\ \(0\)\
\-\ no\\ treatment\\ or\\ followup\\ neccessary\\.\ \(0\)\
\-\ bilateral\\ screen\\ film\\ cc\\ and\\ mlo\\ views\\ of\\ the\\ breast\\ were\\ performed\\.\\ \\ metallic\\ bb\\ markers\\ were\\ placed\\ over\\ the\\ nipples\\ and\\ two\\ small\\ skin\\ lesions\\ on\\ each\\ breast\\.\\ \\ no\\ palpable\\ abnormality\\ is\\ present\\.\\ within\\ the\\ 6\\ o\\'clock\\ position\\ of\\ the\\ left\\ breast\\ in\\ the\\ retroglandular\\ fat\\,\\ is\\ an\\ area\\ of\\ fat\\ and\\ glandular\\ tissue\\ separate\\ from\\ the\\ normal\\ breast\\ parenchyma\\.\\ \\ patient\\ was\\ called\\ back\\ for\\ spot\\ compression\\ and\\ magnification\\ views\\ of\\ the\\ left\\ breast\\ lower\\ half\\.\\ \\ these\\ extra\\ views\\ show\\ to\\ better\\ advantage\\ the\\ separate\\ glandular\\ tissue\\ and\\ fat\\ that\\ is\\ surrounded\\ by\\ a\\ pseudocapsule\\.\\ \\ this\\ pseudocapsule\\ is\\ best\\ appreciated\\ on\\ the\\ spot\\ magnification\\ view\\.\\ the\\ above\\ findings\\ are\\ consistent\\ with\\ a\\ hamartoma\\ of\\ the\\ breast\\.\ \(0\)\
\-\ breast\\ hamartoma\\ \\(fibroadenolipoma\\)\ \(0\)\
\-\ hamartoma\ \(55\)\
\-\ 40\\ year\\ old\\ asymptomatic\\ woman\\ comes\\ to\\ breast\\ imaging\\ center\\ for\\ first\\ screening\\ mammogram\\.\ \(1\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.5082973655589315\ \(0\)\
\-\ hamartoma\\:\\ 0\\.22950320811753044\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.21459546216093425\ \(0\)\
\-\ bb\\:\\ 0\\.21095427831073488\ \(0\)\
\-\ glandular\\:\\ 0\\.19989790441658845\ \(0\)\
\-\ magnification\\:\\ 0\\.1938131427785059\ \(0\)\
\-\ the\\:\\ 0\\.1862256383750909\ \(0\)\
\-\ views\\:\\ 0\\.18416217410794183\ \(0\)\
\-\ metallic\\:\\ 0\\.1644685710915264\ \(0\)\
\-\ separate\\:\\ 0\\.15601115075161237\ \(0\)\
\-\ spot\\:\\ 0\\.1518077124825114\ \(0\)\
\-\ fat\\:\\ 0\\.14514135415655363\ \(0\)\
\-\ moles\\:\\ 0\\.12437813516881419\ \(0\)\
\-\ skin\\:\\ 0\\.1157136905820399\ \(0\)\
\-\ neccessary\\:\\ 0\\.11492763716209081\ \(0\)\
\-\ retroglandular\\:\\ 0\\.11188525634304955\ \(0\)\
\-\ fibroadenolipoma\\:\\ 0\\.11188525634304955\ \(0\)\
\-\ palpable\\:\\ 0\\.10927866923989922\ \(0\)\
\-\ nipples\\:\\ 0\\.10547713915536744\ \(0\)\
\-\ advantage\\:\\ 0\\.09784723307374374\ \(0\)\
\-\ two\\:\\ 0\\.09237329270080623\ \(0\)\
\-\ markers\\:\\ 0\\.08994187951056151\ \(0\)\
\-\ comes\\:\\ 0\\.08940713698852178\ \(0\)\
\-\ mlo\\:\\ 0\\.08657614314192068\ \(0\)\
\-\ is\\:\\ 0\\.08519614891308067\ \(0\)\
\-\ tissue\\:\\ 0\\.08159735380397648\ \(0\)\
\-\ and\\:\\ 0\\.08035559782299384\ \(0\)\
\-\ small\\:\\ 0\\.08023726974188126\ \(0\)\
\-\ screen\\:\\ 0\\.08022138878794877\ \(0\)\
\-\ were\\:\\ 0\\.08018087184542441\ \(0\)\
\-\ surrounded\\:\\ 0\\.0799566389817984\ \(0\)\
\-\ of\\:\\ 0\\.07610049125601409\ \(0\)\
\-\ no\\:\\ 0\\.0758740119172264\ \(0\)\
\-\ cc\\:\\ 0\\.07533170851987454\ \(0\)\
\-\ mammogram\\:\\ 0\\.07425476578006865\ \(0\)\
\-\ each\\:\\ 0\\.07374660062825415\ \(0\)\
\-\ better\\:\\ 0\\.07341805011322376\ \(0\)\
\-\ half\\:\\ 0\\.07325669690925733\ \(0\)\
\-\ called\\:\\ 0\\.07262972729411768\ \(0\)\
\-\ center\\:\\ 0\\.0703756692941825\ \(0\)\
\-\ appreciated\\:\\ 0\\.07011841285816206\ \(0\)\
\-\ followup\\:\\ 0\\.06866917164667491\ \(0\)\
\-\ extra\\:\\ 0\\.06533210865686342\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06317922928739429\ \(0\)\
\-\ screening\\:\\ 0\\.06317922928739429\ \(0\)\
\-\ best\\:\\ 0\\.06257982785879011\ \(0\)\
\-\ position\\:\\ 0\\.06200567200917671\ \(0\)\
\-\ placed\\:\\ 0\\.060604352094784035\ \(0\)\
\-\ marked\\:\\ 0\\.05882345215290863\ \(0\)\
\-\ film\\:\\ 0\\.0581185459667521\ \(0\)\
\-\ 40\\:\\ 0\\.05719903895928771\ \(0\)\
\-\ compression\\:\\ 0\\.05695425345045151\ \(0\)\
\-\ view\\:\\ 0\\.05695425345045151\ \(0\)\
\-\ abnormality\\:\\ 0\\.05657151430795314\ \(0\)\
\-\ abnormalities\\:\\ 0\\.05633764602487669\ \(0\)\
\-\ above\\:\\ 0\\.05610772174623865\ \(0\)\
\-\ factoid\\:\\ 0\\.05431565920298247\ \(0\)\
\-\ left\\:\\ 0\\.05306106176398063\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.05294729528409198\ \(0\)\
\-\ first\\:\\ 0\\.05248507520223716\ \(0\)\
\-\ back\\:\\ 0\\.05186989476777863\ \(0\)\
\-\ area\\:\\ 0\\.05038335606768667\ \(0\)\
\-\ show\\:\\ 0\\.04937295414618525\ \(0\)\
\-\ see\\:\\ 0\\.04838045138551787\ \(0\)\
\-\ for\\:\\ 0\\.04714562400397922\ \(0\)\
\-\ on\\:\\ 0\\.046978384146932874\ \(0\)\
\-\ performed\\:\\ 0\\.04601156610690937\ \(0\)\
\-\ lesions\\:\\ 0\\.04466669791608057\ \(0\)\
\-\ these\\:\\ 0\\.043919169493479855\ \(0\)\
\-\ over\\:\\ 0\\.04324596416795395\ \(0\)\
\-\ consistent\\:\\ 0\\.04217104405442569\ \(0\)\
\-\ bilateral\\:\\ 0\\.04179881168670576\ \(0\)\
\-\ imaging\\:\\ 0\\.04087305890103049\ \(0\)\
\-\ woman\\:\\ 0\\.04050514163310503\ \(0\)\
\-\ present\\:\\ 0\\.03990855079750363\ \(0\)\
\-\ lower\\:\\ 0\\.039742783568804875\ \(0\)\
\-\ to\\:\\ 0\\.038886875081270054\ \(0\)\
\-\ in\\:\\ 0\\.038695473962657524\ \(0\)\
\-\ findings\\:\\ 0\\.038384766824116075\ \(0\)\
\-\ treatment\\:\\ 0\\.037048055103670936\ \(0\)\
\-\ within\\:\\ 0\\.03582047250915471\ \(0\)\
\-\ that\\:\\ 0\\.03375115612350364\ \(0\)\
\-\ by\\:\\ 0\\.03302750449778106\ \(0\)\
\-\ normal\\:\\ 0\\.03175475020052198\ \(0\)\
\-\ from\\:\\ 0\\.030888678998651362\ \(0\)\
\-\ with\\:\\ 0\\.030458384512562327\ \(0\)\
\-\ an\\:\\ 0\\.029740654674815785\ \(0\)\
\-\ are\\:\\ 0\\.02951183293800693\ \(0\)\
\-\ was\\:\\ 0\\.027105134898410266\ \(0\)\
\-\ or\\:\\ 0\\.02705631539947298\ \(0\)\
\-\ this\\:\\ 0\\.02672467112754069\ \(0\)\
\-\ patient\\:\\ 0\\.02529609535381283\ \(0\)\
\-\ year\\:\\ 0\\.0239685268913634\ \(0\)\
\-\ old\\:\\ 0\\.02301808272719324\ \(0\)\
